Wendy Harrison, CEO of the SCI Foundation, outlines the importance of putting parasitic infections on the map, with a particular focus on schistosomiasis.
Researchers are developing a new Alzheimer's disease detection sensor that can be used in the early stages of Alzheimers and a number of other diseases.
Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for the detection of Alzheimer’s disease and how soon in the disease’s trajectory detection can make a meaningful difference in a patient’s prognosis.
Asthma is a chronic inflammatory disease that is characterized by bronchial hyperreactivity (wheezing due to narrowing of the airways) and it disproportionately affects African Americans.
Dr Prebo Barango and Prof Jean-Marie Dangou from the WHO Regional Office for Africa argue that reducing the burden of cardiovascular diseases in Africa is imperative.
Dr Stacey Lockyer, Senior Nutrition Scientist at the British Nutrition Foundation, walks us through understanding diabetes & reducing the risk of type 2 diabetes.
After decades of failure for Alzheimer’s researchers, Lecanemab could open the door to a new ear of drugs to treat Alzheimer’s disease – the world's most common form of dementia.
COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease – increasing the risk of future potential neurodegenerative conditions.
Alzheimers drugs have been shown able to target insulin receptors located in cerebral microvessels, massively expanding the future of drug production and testing
